1. https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-surface-coatings-general-issues-consideration-regarding-parenteral-administration_en.pdf (accessed July 18, 2020).
2. Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation, https://www.fda.gov/media/70837/download (accessed July 18, 2020).
3. https://www.ema.europa.eu/en/documents/scientific-guideline/joint-mhlw/ema-reflection-paper-development-block-copolymer-micelle-medicinal-products_en.pdf (accessed July 18, 2020).
4. https://www.ema.europa.eu/en/data-requirements-intravenous-liposomal-products-developed-reference-innovator-liposomal-product (accessed July 18, 2020).
5. EMA Regulatory Science to 2025, https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ema-regulatory-science-2025-strategic-reflection_en.pdf (accessed July 18, 2020)